Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

Lifeforce, the world's leading longevity medicine program, has introduced the Lifeforce Brain Protection Program, a first-of-its-kind solution for people wanting to proactively take control of their ...

Molecular Neurodegeneration. This advanced course covers several of the most important molecules involved in neurodegenerative disease, including Aβ, tau, apoE, TDP-43, α-synuclein, LRRK2, prion ...

Further investigations to narrow down the chromosomal region associated with dementia, and to explore the link with APOE, are warranted. The results imply that other tau kinases should be ...

The scientists concluded that while the two markers perform similarly, they yield complementary information, and sequential ...

APOE ε3 is the most common and is seen as neutral ... these polymorphisms were associated with amyloid-beta and phosphorylated tau proteins—both significant biomarkers for Alzheimer's disease.

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...